Cleveland Clinic researchers leading a global clinical trial have found that Rilonacept, an FDA approved drug for other inflammatory diseases, resolved acute pericarditis episodes and reduced risk of pericarditis recurrence.
from Medindia Health News https://ift.tt/2He3sa4
No comments:
Post a Comment